FDA Warning Letter — CHRONIC LYME TREATMENTS
The FDA took a Warning Letter action against CHRONIC LYME TREATMENTS on May 7, 2020 (Squamish, Canada). The action was issued by CDER and concerns drugs products.
Action details
- Facility
- CHRONIC LYME TREATMENTS
- Date
- May 7, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Center
- CDER
- Location
- Squamish (Canada)